Gerard Brophy's Insider Trades & SAST Disclosures
Gerard Brophy's most recent trade in Avantor Inc. was a trade of 19,683 Common Stock done at an average price of $20.3 . Disclosure was reported to the exchange on May 17, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gerard Brophy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.28 per share. | 17 May 2023 | 19,683 | 89,032 (0%) | 0% | 20.3 | 399,171 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 03 Mar 2023 | 3,914 | 108,715 (0%) | 0% | 25 | 97,850 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 27 Feb 2023 | 3,059 | 112,629 (0%) | 0% | 25 | 76,475 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 49,215 | 49,215 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,308 | 117,728 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.62 per share. | 23 Feb 2023 | 2,040 | 115,688 (0%) | 0% | 24.6 | 50,225 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.59 per share. | 23 Feb 2023 | 1,893 | 97,420 (0%) | 0% | 24.6 | 46,549 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.54 per share. | 20 Feb 2023 | 3,072 | 99,313 (0%) | 0% | 24.5 | 75,387 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 38,737 | 128,945 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.90 per share. | 31 Jan 2023 | 15,221 | 113,724 (0%) | 0% | 23.9 | 363,782 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 31 Jan 2023 | 11,339 | 102,385 (0%) | 0% | 25.1 | 284,155 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 02 Jan 2023 | 6,727 | 90,208 (0%) | 0% | 21.1 | 141,872 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 31.27 per share. | 20 May 2022 | 19,603 | 96,935 (0%) | 0% | 31.3 | 612,986 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.33 per share. | 17 May 2022 | 19,683 | 116,538 (0%) | 0% | 31.3 | 616,668 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 34.47 per share. | 01 Mar 2022 | 2,027 | 136,221 (0%) | 0% | 34.5 | 69,871 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 43,708 | 43,708 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 15,110 | 140,291 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 33.79 per share. | 23 Feb 2022 | 3,059 | 125,181 (0%) | 0% | 33.8 | 103,364 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.39 per share. | 23 Feb 2022 | 2,043 | 138,248 (0%) | 0% | 35.4 | 72,302 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.00 per share. | 20 Feb 2022 | 3,072 | 128,240 (0%) | 0% | 34 | 104,448 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 02 Jan 2022 | 59,418 | 202,281 (0%) | 0% | 18.4 | 1,096,262 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 40.77 per share. | 02 Jan 2022 | 59,418 | 142,863 (0%) | 0% | 40.8 | 2,422,472 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2022 | 59,418 | 59,417 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 38.65 per share. | 02 Jan 2022 | 11,551 | 131,312 (0%) | 0% | 38.6 | 446,446 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.14 per share. | 02 Jan 2022 | 6,516 | 142,863 (0%) | 0% | 42.1 | 274,584 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 37.24 per share. | 30 Jul 2021 | 81,125 | 149,379 (0%) | 0% | 37.2 | 3,021,095 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2021 | 81,125 | 81,125 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.20 per share. | 30 Jul 2021 | 81,125 | 230,504 (0%) | 0% | 23.2 | 1,882,100 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 31.10 per share. | 20 May 2021 | 19,603 | 149,379 (0%) | 0% | 31.1 | 609,653 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.90 per share. | 17 May 2021 | 19,683 | 168,982 (0%) | 0% | 30.9 | 608,205 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 52,693 | 52,693 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 16,281 | 188,665 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 27.93 per share. | 24 Feb 2021 | 3,059 | 172,384 (0%) | 0% | 27.9 | 85,438 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 28.62 per share. | 22 Feb 2021 | 19,769 | 175,443 (0%) | 0% | 28.6 | 565,789 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 19,769 | 59,306 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.67 per share. | 22 Feb 2021 | 19,769 | 195,212 (0%) | 0% | 17.7 | 349,318 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.69 per share. | 22 Feb 2021 | 3,072 | 175,443 (0%) | 0% | 28.7 | 88,136 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.20 per share. | 11 Jan 2021 | 216,332 | 394,847 (0%) | 0% | 23.2 | 5,018,902 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 11 Jan 2021 | 216,332 | 178,515 (0%) | 0% | 30.1 | 6,507,267 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 162,248 | 162,250 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 11 Jan 2021 | 162,248 | 178,515 (0%) | 0% | 30.0 | 4,873,930 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.20 per share. | 11 Jan 2021 | 162,248 | 340,763 (0%) | 0% | 23.2 | 3,764,154 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 27.24 per share. | 06 Jan 2021 | 11,509 | 178,515 (0%) | 0% | 27.2 | 313,505 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2021 | 59,418 | 118,835 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Sale of securities on an exchange or to another person at price $ 27.84 per share. | 02 Jan 2021 | 59,418 | 190,024 (0%) | 0% | 27.8 | 1,654,197 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 02 Jan 2021 | 59,418 | 249,442 (0%) | 0% | 18.4 | 1,096,262 | Common Stock |
| Avantor Inc. | Gerard Brophy | EVP, Biopharma Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.15 per share. | 02 Jan 2021 | 6,559 | 190,024 (0%) | 0% | 28.2 | 184,636 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges